TEVA PHARMACEUTICAL-SP ADR (TEVA) Institutional Ownership Changes & 13F Activity
TEVA PHARMACEUTICAL-SP ADR (TEVA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Sound Shore Management, Greenlight Capital, ARK Invest, Sequoia Financial Advisors, and Viking Global Investors.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2015 | Renaissance Technologies LLC | Buy | 374,300 | 1,338,963 | $83,417 |
| Q1 2015 | Viking Global Investors | Buy | 228,600 | 228,600 | $14,242 |
| Q1 2015 | Matrix Advisors Value Fund | Buy | 4,389 | 368,103 | $22,933 |
| Q1 2015 | Muhlenkamp & Co | Buy | 325 | 176,710 | $11,009 |
| Q4 2014 | First Eagle U.S. Value | Buy | 1,027,730 | 2,448,310 | $140,803 |
| Q4 2014 | Renaissance Technologies LLC | Buy | 699,800 | 964,663 | $55,478 |
| Q4 2014 | Muhlenkamp & Co | Sell | -470 | 176,385 | $10,144 |
| Q4 2014 | Matrix Advisors Value Fund | Buy | 252 | 363,714 | $20,917 |
| Q3 2014 | First Eagle U.S. Value | Buy | 1,420,380 | 1,420,580 | $76,356 |
| Q3 2014 | Renaissance Technologies LLC | Sell | -239,800 | 264,863 | $14,236 |
| Q3 2014 | Matrix Advisors Value Fund | Sell | -1,710 | 363,462 | $19,536 |
| Q2 2014 | Renaissance Technologies LLC | Buy | 206,300 | 504,663 | $26,454 |
| Q2 2014 | Matrix Advisors Value Fund | Sell | -5,305 | 365,172 | $19,142 |
| Q2 2014 | Muhlenkamp & Co | Buy | 1,415 | 176,855 | $9,271 |
| Q1 2014 | Matrix Advisors Value Fund | Sell | -54,984 | 370,477 | $19,576 |
| Q1 2014 | Muhlenkamp & Co | Sell | -900 | 175,440 | $9,270 |
| Q4 2013 | Matrix Advisors Value Fund | Sell | -25,153 | 425,461 | $17,052 |
| Q4 2013 | Muhlenkamp & Co | Buy | 6,355 | 176,340 | $7,068 |
| Q3 2013 | Matrix Advisors Value Fund | Buy | 5,355 | 450,614 | $17,024 |
| Q3 2013 | Muhlenkamp & Co | Buy | 325 | 169,985 | $6,422 |
| Q2 2013 | Abrams Capital Management | Buy | 2,561,269 | 2,561,269 | $100,402 |
| Q2 2013 | Matrix Advisors Value Fund | Buy | 445,259 | 445,259 | $17,454 |
| Q2 2013 | Renaissance Technologies LLC | Buy | 298,363 | 298,363 | $11,696 |
| Q2 2013 | Muhlenkamp & Co | Buy | 169,660 | 169,660 | $6,651 |
| Q2 2013 | Eagle Capital Management | Buy | 22,400 | 22,400 | $878 |
| Q2 2013 | First Eagle U.S. Value | Buy | 200 | 200 | $8 |
Frequently asked questions about TEVA activity
Which institutional owners are buying TEVA?
Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TEVA activity?
"Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TEVA increasing?
Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TEVA Institutional Insights
- TEVA Institutional Ownership Overview
- TEVA Institutional Ownership & Insiders Activity
- TEVA Institutional Ownership & 13F Activity
- TEVA Top Institutional Shareholders
- TEVA Institutional Buying Activity
- TEVA Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TEVA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings